1 results match your criteria: "Dept of Surgery North Shore Univ. Hosp. Division of Surgical Oncology[Affiliation]"
The therapeutic value of monoclonal antibodies directed against immunogenic tumor glycoproteins.
J Cancer
November 2010
Dept of Surgery North Shore Univ. Hosp. Division of Surgical Oncology, Manhasset NY, USA; Med. Univ of South Carolina and Neogenix Oncology Inc. Great Neck NY, USA.
Monoclonal antibodies developed against immunogenic proteins (Tumor Specific Antigens/TSA's) that are expressed in human cancers, display a unique behavioral pattern. They appear to serve in a dual role. This includes the early recognition of these immunogenic membrane proteins that can serve as diagnostic markers, and the targeting of such markers for the destruction of the tumor, primarily thru ADCC.
View Article and Find Full Text PDF